Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRD303 for Postoperative Analgesia After Abdominal Surgery
NCT07353307Phase 3Completed
- Sponsor
- Third Xiangya Hospital, Central South University
- Start
- Dec 2025
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of TRD303 in postoperative pain, sponsored by Third Xiangya Hospital, Central South University. Started Dec 2025; status: completed.
02
Drugs
TRD303
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07353307.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07353307.